Cargando…
Cyclic GMP Kinase I Modulates Glucagon Release From Pancreatic α-Cells
OBJECTIVE: The physiologic significance of the nitric oxide (NO)/cGMP signaling pathway in islets is unclear. We hypothesized that cGMP-dependent protein kinase type I (cGKI) is directly involved in the secretion of islet hormones and glucose homeostasis. RESEARCH DESIGN AND METHODS: Gene-targeted m...
Autores principales: | Leiss, Veronika, Friebe, Andreas, Welling, Andrea, Hofmann, Franz, Lukowski, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012166/ https://www.ncbi.nlm.nih.gov/pubmed/20978093 http://dx.doi.org/10.2337/db10-0595 |
Ejemplares similares
-
cGMP kinase I regulates glucagon release
por: Leiss, Veronika, et al.
Publicado: (2009) -
Phosphatidylinositol-4-Phosphate-5-Kinase α Deficiency Alters Dynamics of Glucose-Stimulated Insulin Release to Improve Glucohomeostasis and Decrease Obesity in Mice
por: Huang, Ping, et al.
Publicado: (2011) -
Selective inhibition of intestinal guanosine 3′,5′-cyclic monophosphate signaling by small-molecule protein kinase inhibitors
por: Bijvelds, Marcel J. C., et al.
Publicado: (2018) -
γ-Hydroxybutyrate does not mediate glucose inhibition of glucagon secretion
por: Yu, Qian, et al.
Publicado: (2020) -
Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
por: Bassi, Rekha, et al.
Publicado: (2017)